Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

How to treat male breast cancer.

Czene K, Bergqvist J, Hall P, Bergh J.

Breast. 2007 Dec;16 Suppl 2:S147-54. Review. Erratum in: Breast. 2008 Jun;17(3):319. Kamila, Czene [corrected to Czene, Kamila]; Jenny, Bergqvist [corrected to Bergqvist, Jenny]; Per, Hall [corrected to Hall, Per]; Jonas, Bergh [corrected to Bergh, Jonas].

PMID:
18210656
2.

[Three men with breast cancer].

Bergs EA, Tanis PJ, Steller EP.

Ned Tijdschr Geneeskd. 2005 Mar 5;149(10):534-7. Dutch.

PMID:
15782690
3.

Understanding and management of male breast cancer: a critical review.

Pant K, Dutta U.

Med Oncol. 2008;25(3):294-8. Epub 2007 Dec 12. Review.

PMID:
18074245
4.

Never too late: reducing late breast cancer relapse risk.

Harbeck N.

Curr Med Res Opin. 2008 Dec;24(12):3295-305. doi: 10.1185/03007990802470639 . Review.

PMID:
18954499
5.

Safely promoting breast-conserving surgery and preventing early relapses with an aromatase inhibitor.

Markopoulos C.

Surg Oncol. 2008 Aug;17(2):113-28. doi: 10.1016/j.suronc.2007.11.006. Epub 2008 Jan 4. Review.

PMID:
18178077
6.

Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?

Tang SC.

Cancer Invest. 2008 Jun;26(5):481-90. doi: 10.1080/07357900701781812. Review.

PMID:
18568770
7.

Current controversies in extended adjuvant endocrine therapy for early breast cancer.

Snoj N, Paridaens R, Cufer T.

Curr Opin Oncol. 2008 Nov;20(6):627-33. doi: 10.1097/CCO.0b013e3283136770. Review.

PMID:
18841043
8.

[Clinical research advancement on male breast cancer].

Xue Y, Guo XT, Liu WC.

Ai Zheng. 2007 Oct;26(10):1148-52. Review. Chinese.

PMID:
17927890
9.

Pharmacotherapy for male breast cancer.

Hayes T.

Expert Opin Pharmacother. 2002 Jun;3(6):701-8. Review.

PMID:
12036409
10.

Aromatase inhibitors: a new reality for the adjuvant endocrine treatment of early-stage breast cancer in postmenopausal women.

Colozza M, Califano R, Minenza E, Dinh P, Azambuja E.

Mini Rev Med Chem. 2008 Jun;8(6):564-74. Review.

PMID:
18537711
11.

Factors predictive of response to hormone therapy in breast cancer.

Rastelli F, Crispino S.

Tumori. 2008 May-Jun;94(3):370-83. Review.

12.

Male breast cancer.

Gómez-Raposo C, Zambrana Tévar F, Sereno Moyano M, López Gómez M, Casado E.

Cancer Treat Rev. 2010 Oct;36(6):451-7. doi: 10.1016/j.ctrv.2010.02.002. Epub 2010 Mar 2. Review.

PMID:
20193984
13.

Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancer.

Toi M, Yamashiro H, Tsuji W.

Breast Cancer. 2009;16(3):207-18. doi: 10.1007/s12282-009-0096-x. Epub 2009 Mar 4. Review.

PMID:
19259765
14.

A review of the BIG results: the Breast International Group 1-98 trial analyses.

Doughty JC.

Breast. 2008 Jan;17 Suppl 1:S9-S14. doi: 10.1016/S0960-9776(08)70003-1. Review.

PMID:
18279765
15.

Breast cancer (non-metastatic).

Rodger A, Stebbing J, Thompson AM.

Clin Evid. 2006 Jun;(15):2360-92. Review. No abstract available.

PMID:
16973090
16.

Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.

Ellis MJ, Tao Y, Luo J, A'Hern R, Evans DB, Bhatnagar AS, Chaudri Ross HA, von Kameke A, Miller WR, Smith I, Eiermann W, Dowsett M.

J Natl Cancer Inst. 2008 Oct 1;100(19):1380-8. doi: 10.1093/jnci/djn309. Epub 2008 Sep 23.

17.

Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen.

Carpenter R.

Eur J Surg Oncol. 2008 Jul;34(7):746-55. doi: 10.1016/j.ejso.2008.01.011. Epub 2008 Mar 4. Review.

PMID:
18296017
18.

Aromatase inhibitors and male breast cancer.

Arriola E, Hui E, Dowsett M, Smith IE.

Clin Transl Oncol. 2007 Mar;9(3):192-4.

PMID:
17403631
19.

Optimizing aromatase inhibitor integration into initial treatment strategies in postmenopausal women with hormone-receptor-positive early breast cancer.

Chlebowski RT.

Breast Cancer Res Treat. 2008 Dec;112 Suppl 1:25-34. doi: 10.1007/s10549-008-0237-5. Epub 2008 Dec 20.

PMID:
19101792
20.

Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer.

Schwartzberg LS, Cobb P, Senecal F, Henry D, Kulig K, Walker MS, Houts AC, Stepanski EJ.

Breast. 2009 Apr;18(2):78-83. doi: 10.1016/j.breast.2009.01.002. Epub 2009 Apr 1.

PMID:
19342237

Supplemental Content

Support Center